| Autor: |
Concin N; Department of Gynecology and Obstetrics, Medical University of Innsbruck, Innsbruck, Austria N.Concin@kem-med.com.; Department of Gynecology and Gynecological Oncology, Evangelische Kliniken Essen-Mitte, Essen, Germany., Ray-Coquard I; University Claude Bernard & Medical Oncology Centre Léon Bérard, GINECO group, Lyon, France., Glasspool RM; Department of Medical Oncology, Beatson West of Scotland Cancer Centre and University of Glasgow, Glasgow, UK., Braicu E; Department of Gynecology, Campus Virchow Klinikum, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Farrelly L; Cancer Research UK & University College London Cancer Trials Centre, London, UK., Votan B; ARCAGY-GINECO, Paris, France., Mirza MR; Department of Oncology, Rigshospitalet; Copenhagen University Hospital, Copenhagen, Denmark., Gonzalez Martin A; Department of Medical Oncology, Clinica Universidad de Navarra, Madrid, Madrid, Spain., Vergote I; Department of Gynecology and Obstetrics, Gynecologic Oncology, Leuven Cancer Institute, Catholic University Leuven, Leuven, Belgium., Pignata S; Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale Napoli, Naples, Italy. |
